Literature DB >> 26464470

A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States.

Anne Marie France, Juliana Grant, J Steve Kammerer, Thomas R Navin.   

Abstract

Tuberculosis genotyping data are frequently used to estimate the proportion of tuberculosis cases in a population that are attributable to recent transmission (RT). Multiple factors influence genotype-based estimates of RT and limit the comparison of estimates over time and across geographic units. Additionally, methods used for these estimates have not been validated against field-based epidemiologic assessments of RT. Here we describe a novel genotype-based approach to estimation of RT based on the identification of plausible-source cases, which facilitates systematic comparisons over time and across geographic areas. We compared this and other genotype-based RT estimation approaches with the gold standard of field-based assessment of RT based on epidemiologic investigation in Arkansas, Maryland, and Massachusetts during 1996-2000. We calculated the sensitivity and specificity of each approach for epidemiologic evidence of RT and calculated the accuracy of each approach across a range of hypothetical RT prevalence rates plausible for the United States. The sensitivity, specificity, and accuracy of genotype-based RT estimates varied by approach. At an RT prevalence of 10%, accuracy ranged from 88.5% for state-based clustering to 94.4% with our novel approach. Our novel, field-validated approach allows for systematic assessments over time and across public health jurisdictions of varying geographic size, with an established level of accuracy. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  disease transmission; genotyping; molecular epidemiology; recent transmission; tuberculosis

Mesh:

Year:  2015        PMID: 26464470      PMCID: PMC5996379          DOI: 10.1093/aje/kwv121

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

1.  Methodological problems in the molecular epidemiology of tuberculosis.

Authors:  Megan Murray; David Alland
Journal:  Am J Epidemiol       Date:  2002-03-15       Impact factor: 4.897

2.  Unsuspected recent transmission of tuberculosis among high-risk groups: implications of universal tuberculosis genotyping in its detection.

Authors:  Naile Malakmadze; Idalia M González; Tanya Oemig; Ijeoma Isiadinso; Desiree Rembert; Mary M McCauley; Philip Wand; Lois Diem; Lauren Cowan; Gabriel J Palumbo; Michael Fraser; Kashef Ijaz
Journal:  Clin Infect Dis       Date:  2005-01-07       Impact factor: 9.079

3.  Molecular epidemiology of tuberculosis in England, 1998.

Authors:  J Love; P Sonnenberg; J R Glynn; A Gibson; K Gopaul; Z Fang; F Le Brun; R Pitman; A C Hayward; J Innes; C Van den Bosch; V Delpech; F Drobniewski; J M Watson
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

4.  The prognosis of a positive tuberculin reaction in childhood and adolescence.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Epidemiol       Date:  1974-02       Impact factor: 4.897

Review 5.  Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli.

Authors:  I Sutherland
Journal:  Adv Tuberc Res       Date:  1976

6.  Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island.

Authors:  Jessica Vanhomwegen; Awewura Kwara; Melissa Martin; Fizza S Gillani; Arnaud Fontanet; Peninnah Mutungi; Joyce Crellin; Stephen Obaro; Michael Gosciminski; E Jane Carter; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

7.  Molecular epidemiology of tuberculosis in a sentinel surveillance population.

Authors:  Barbara A Ellis; Jack T Crawford; Christopher R Braden; Scott J N McNabb; Marisa Moore; Steve Kammerer
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

8.  Population-based molecular epidemiological study of tuberculosis in Malatya, Turkey.

Authors:  Riza Durmaz; Thierry Zozio; Selami Gunal; Caroline Allix; Maryse Fauville-Dufaux; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

9.  Long-term molecular analysis of tuberculosis strains in alabama, a state characterized by a largely indigenous, low-risk population.

Authors:  Mirjam-Colette Kempf; Nancy E Dunlap; Kerry H Lok; William H Benjamin; Nancy B Keenan; Michael E Kimerling
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 10.  Tuberculosis outbreak investigations in the United States, 2002-2008.

Authors:  Kiren Mitruka; John E Oeltmann; Kashef Ijaz; Maryam B Haddad
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

View more
  36 in total

1.  QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.

Authors:  Jung-Yien Chien; Hsiu-Tzy Chiang; Min-Chi Lu; Wen-Chien Ko; Chong-Jen Yu; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

2.  Estimating the relative probability of direct transmission between infectious disease patients.

Authors:  Sarah V Leavitt; Robyn S Lee; Paola Sebastiani; C Robert Horsburgh; Helen E Jenkins; Laura F White
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

Review 3.  Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

Authors:  Philip A LoBue; Jonathan H Mermin
Journal:  Lancet Infect Dis       Date:  2017-05-08       Impact factor: 25.071

4.  Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas.

Authors:  Sourya Shrestha; Andrew N Hill; Suzanne M Marks; David W Dowdy
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

5.  Spatial clusters of latent tuberculous infection, Connecticut, 2010-2014.

Authors:  J Mullins; M N Lobato; K Bemis; L Sosa
Journal:  Int J Tuberc Lung Dis       Date:  2018-02-01       Impact factor: 2.373

Review 6.  Epidemiology of Tuberculosis in the United States.

Authors:  Adam J Langer; Thomas R Navin; Carla A Winston; Philip LoBue
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

7.  Changes in tuberculosis epidemiology, United States, 1993-2017.

Authors:  L R Armstrong; C A Winston; B Stewart; C A Tsang; A J Langer; T R Navin
Journal:  Int J Tuberc Lung Dis       Date:  2019-07-01       Impact factor: 2.373

Review 8.  The impact of migration on tuberculosis in the United States.

Authors:  N A Menzies; A N Hill; T Cohen; J A Salomon
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

9.  Tuberculosis Transmission or Mortality Among Persons Living with HIV, USA, 2011-2016.

Authors:  K M Schmit; N Shah; S Kammerer; S Bamrah Morris; S M Marks
Journal:  J Racial Ethn Health Disparities       Date:  2020-02-14

10.  Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.

Authors:  Nicolas A Menzies; Ted Cohen; Andrew N Hill; Reza Yaesoubi; Kara Galer; Emory Wolf; Suzanne M Marks; Joshua A Salomon
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.